CHK1/2 Inhibitors for Use in the Treatment of Neuroblastomas and/or Soft Tissue Sarcomas

• 收藏
• 分享

专利权人:

Eli Lilly and Company

发明人:

Louis Frank Stancato

申请号：

US15742889

公开号：

US20180369202A1

申请日:

2016.07.15

申请国别(地区):

US

年份:

2018

代理人:

摘要：

The present invention provides 5-(5-(2-(3-aminopropoxy)-6-methoxyphenyl)-1H-pyrazol-3-ylamino)pyrazine˜2˜carbonitrile and pharmaceutically acceptable salts and solvates thereof that is capable of inhibiting CHK1 and is useful in the treatment of neuroblastomas and/or soft tissue sarcomas.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/